Brief: Aurobindo Pharma Says Unit To Buy 20% Additional Ownership In Luoxin Aurovitas
23/12/2025 08:38
Dec 23 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: UNIT TO BUY 20% ADDITIONAL OWNERSHIP IN LUOXIN AUROVITAS DEAL AT $5.1 MILLION FOR ACQUISITION OF 20% SHARE IN LUOXIN AUROVITAS Source text: ID:nNSE7rtKhw Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11